6SBA
| Crystal Structure of mTEAD with a VGL4 Tertiary Structure Mimetic | 分子名称: | ACETYL GROUP, GLYCEROL, Transcriptional enhancer factor TEF-3, ... | 著者 | Adihou, H, Grossmann, T.N, Waldmann, H, Gasper, R. | 登録日 | 2019-07-19 | 公開日 | 2020-09-30 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (1.3 Å) | 主引用文献 | A protein tertiary structure mimetic modulator of the Hippo signalling pathway. Nat Commun, 11, 2020
|
|
6CFD
| ADEP4 bound to E. faecium ClpP | 分子名称: | (4S)-2-METHYL-2,4-PENTANEDIOL, ATP-dependent Clp protease proteolytic subunit, N-[(6aS,12S,15aS,17R,21R,23aS)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-3,5-difluoro-Nalpha-[(2E)-hept-2-enoyl]-L-phenylalaninamide | 著者 | Lee, R.E, Griffith, E.C. | 登録日 | 2018-02-14 | 公開日 | 2018-05-16 | 最終更新日 | 2023-10-04 | 実験手法 | X-RAY DIFFRACTION (2.57 Å) | 主引用文献 | In VivoandIn VitroEffects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci. Antimicrob. Agents Chemother., 62, 2018
|
|
4WXP
| |
3C7X
| Hemopexin-like domain of matrix metalloproteinase 14 | 分子名称: | CHLORIDE ION, Matrix metalloproteinase-14, SODIUM ION | 著者 | Tochowicz, A, Itoh, Y, Maskos, K, Bode, W, Goettig, P. | 登録日 | 2008-02-08 | 公開日 | 2009-02-10 | 最終更新日 | 2023-11-01 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | The dimer interface of the membrane type 1 matrix metalloproteinase hemopexin domain: crystal structure and biological functions J.Biol.Chem., 286, 2011
|
|
5NZ9
| |
4OS5
| |
4OS1
| Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK601 (bicyclic 1) | 分子名称: | ACETATE ION, SULFATE ION, Urokinase-type plasminogen activator, ... | 著者 | Chen, S, Pojer, F, Heinis, C. | 登録日 | 2014-02-12 | 公開日 | 2014-09-24 | 最終更新日 | 2021-06-02 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides. Nat Chem, 6, 2014
|
|
4OS6
| Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK604 (bicyclic 2) | 分子名称: | ACETATE ION, SULFATE ION, Urokinase-type plasminogen activator, ... | 著者 | Chen, S, Pojer, F, Heinis, C. | 登録日 | 2014-02-12 | 公開日 | 2014-09-24 | 最終更新日 | 2021-06-02 | 実験手法 | X-RAY DIFFRACTION (1.75 Å) | 主引用文献 | Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides. Nat Chem, 6, 2014
|
|
4OS4
| Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK603 (bicyclic 1) | 分子名称: | ACETATE ION, CHLORIDE ION, GLYCEROL, ... | 著者 | Chen, S, Pojer, F, Heinis, C. | 登録日 | 2014-02-12 | 公開日 | 2014-09-24 | 最終更新日 | 2021-06-02 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides. Nat Chem, 6, 2014
|
|
6DUY
| |
6DUW
| |
6DV1
| |
6E4F
| Crystal structure of ARQ 531 in complex with the kinase domain of BTK | 分子名称: | 1,2-ETHANEDIOL, 1,5-anhydro-2-{[5-(2-chloro-4-phenoxybenzene-1-carbonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-2,3,4-trideoxy-D-erythro-hexitol, IMIDAZOLE, ... | 著者 | Eathiraj, S. | 登録日 | 2018-07-17 | 公開日 | 2018-09-05 | 最終更新日 | 2024-03-13 | 実験手法 | X-RAY DIFFRACTION (1.15 Å) | 主引用文献 | The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation. Cancer Discov, 8, 2018
|
|
4OS7
| Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK607 (bicyclic) | 分子名称: | ACETATE ION, GLYCEROL, SULFATE ION, ... | 著者 | Chen, S, Pojer, F, Heinis, C. | 登録日 | 2014-02-12 | 公開日 | 2014-09-24 | 最終更新日 | 2021-06-02 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides. Nat Chem, 6, 2014
|
|
4OS2
| Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK602 (bicyclic 1) | 分子名称: | ACETATE ION, SULFATE ION, Urokinase-type plasminogen activator, ... | 著者 | Chen, S, Pojer, F, Heinis, C. | 登録日 | 2014-02-12 | 公開日 | 2014-09-24 | 最終更新日 | 2021-06-02 | 実験手法 | X-RAY DIFFRACTION (1.79 Å) | 主引用文献 | Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides. Nat Chem, 6, 2014
|
|
6O2W
| |
6O2U
| |
6O2V
| |
6PE6
| PANK3 complex structure with compound PZ-3022 | 分子名称: | 6-{4-[(4-cyclopropylphenyl)acetyl]piperazin-1-yl}pyridazine-3-carbonitrile, MAGNESIUM ION, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, ... | 著者 | White, S.W, Yun, M. | 登録日 | 2019-06-20 | 公開日 | 2020-12-23 | 最終更新日 | 2023-10-11 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia. Sci Transl Med, 13, 2021
|
|
6PKA
| |
6PMD
| |
3UDL
| 3-heterocyclyl quinolone bound to HCV NS5B | 分子名称: | 3-(5-benzyl-1,2,4-oxadiazol-3-yl)-6-fluoro-1-[2-fluoro-4-(trifluoromethyl)benzyl]-7-(4-methylpiperazin-1-yl)quinolin-4(1H)-one, HCV NS5B polymerase | 著者 | Somoza, J.R. | 登録日 | 2011-10-28 | 公開日 | 2011-12-21 | 実験手法 | X-RAY DIFFRACTION (2.174 Å) | 主引用文献 | Quinolones as HCV NS5B polymerase inhibitors. Bioorg.Med.Chem.Lett., 21, 2011
|
|
3PHE
| HCV NS5B with a bound quinolone inhibitor | 分子名称: | 4-chlorobenzyl 6-fluoro-7-(4-methylpiperazin-1-yl)-1-[4-(methylsulfonyl)benzyl]-4-oxo-1,4-dihydroquinoline-3-carboxylate, HCV encoded nonstructural 5B protein | 著者 | Somoza, J.R, To, N, Lehoux, I. | 登録日 | 2010-11-03 | 公開日 | 2010-11-17 | 最終更新日 | 2024-02-21 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Quinolones as HCV NS5B polymerase inhibitors. Bioorg.Med.Chem.Lett., 21, 2011
|
|
6X2U
| |
6X2S
| Crystal Structure of Mek1(NQ)NES peptide bound to CRM | 分子名称: | Dual specificity mitogen-activated protein kinase kinase 1, Exportin-1, GLYCEROL, ... | 著者 | Baumhardt, J.M. | 登録日 | 2020-05-20 | 公開日 | 2020-07-01 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.496 Å) | 主引用文献 | Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation. Mol.Biol.Cell, 31, 2020
|
|